PPreplord UPSCAn IIT Alumni Initiative

UPSC Prelims GS1 2021 Question 65: Vaccines (development)

General Science & Technology › Biotechnology & Health Technology › Vaccines • Concept: development — Vaccines • Marking: +2.0 / −0.667

UPSC GS1 2021 • Q65General Science & TechnologyVaccinesdevelopment

With reference to recent developments regarding ‘Recombinant Vector Vaccine’, consider the following statements: Which of the statements given above is/are correct?

  • 1. Genetic engineering is applied in the development of these vaccines.
  • 2. Bacteria and viruses are used as vectors.

Official Answer & Detailed Explanation

Verified Answer: (C) Both 1 and 2
The recombinant subunit vaccine causes the immune response of the human body by directly injecting the subunit of the pathogen into the body. This method is generally of low immunogenicity and can only induce the humoral immune response of the human body. Therefore, to simultaneously induce the humoral and cellular immune processes of the human body and improve the immunogenicity of vaccines, several technical platforms have been developed to directly produce antigen proteins in the human body. The recombinant virus vector vaccine is one of the important emerging technologies. Recombinant vector vaccines are live replicating viruses that are engineered to carry extra genes derived from a pathogen—and these extra genes produce proteins against which we want to generate immunity. Hence statement 1 is correct. It exposes the body to proteins made by a virus or bacteria, are often made by using weakened or inactive versions of that virus or bacteria. Hence statement 2 is correct.

Option-by-Option Breakdown

Option (A) — Eliminated
1 only
Option (B) — Eliminated
2 only
Option (C) — Correct Answer
Both 1 and 2
Option (D) — Eliminated
Neither 1 nor 2

UPSC Prelims Topic Weightage & Syllabus Context (2011–2026)

Vaccines under General Science & Technology has appeared 4 times in UPSC CSE Prelims GS1 between 2021–2026. Practicing all PYQs from this topic in timed batches helps build pattern recognition and cuts down negative-marking traps.

Frequently Asked Questions

What is the correct answer to UPSC Prelims GS1 2021 Question 65?
The officially verified correct answer is Option (C): Both 1 and 2.
Which UPSC Prelims syllabus topic does GS1 2021 Q65 belong to?
This question is categorized under General Science & Technology (Biotechnology & Health Technology) → Vaccines → development. Across 2011–2026, UPSC has asked 4 PYQs from this topic.
What is the marking scheme and ideal time for this UPSC GS1 question?
UPSC GS Paper 1 awards +2.0 marks for a correct answer and deducts 0.667 marks for an incorrect attempt. Aim to solve this question within 72 seconds.

Related UPSC GS1 PYQs on Vaccines